Device Trial Radar · NCT05916950
The THOR IDE Study
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
155
Planned (sponsor's estimate)
Start
Oct 29, 2024
Primary completion
Dec 2026
Study completion Dec 2027
Sponsor
- Lead sponsor
- Philips Clinical & Medical Affairs GlobalPublic (PHG)
- Sponsor type
- Industry
- Collaborators
- NAMSA; Syntropic
- First posted
- Jun 23, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to test the Thor system in adult (≥ 18 year old) patients with de novo (new, never treated) calcified lesions in infrainguinal (leg) arteries (peripheral artery disease or PAD). The main question\[s\] it aims to answer are: * Is the Thor system safe in treating these lesions * Does the Thor system work to treat these lesions Participants will: * Receive treatment with the Thor system * Have follow-up visits at Discharge, 30 days, 6 months, and 12 months
Conditions
- Peripheral Artery Disease
- Peripheral Artery Stenosis
- Peripheral Artery Calcification
- PAD
Interventions
Thor laser atherectomyDevice
Treatment of de novo calcified lesions with laser atherectomy and calcium modification using the Thor system
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom from Major Adverse Events (MAEs)Time frame: 30 Days
- Procedural SuccessTime frame: At completion of the procedure
Locations
29 sites in 1 country. Site status is shown where the registry gives one.
St. Helena Hospital
St. Helena, California · Withdrawn
Rocky Mountain Regional VA Medical Center
Aurora, Colorado · Recruiting
Manatee Memorial Hospital
Bradenton, Florida · Recruiting
26 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.